A detailed history of Cora Capital Advisors LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Cora Capital Advisors LLC holds 16,800 shares of AMRN stock, worth $7,392. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,800
Previous 16,800 -0.0%
Holding current value
$7,392
Previous $11.6 Million 8.88%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$0.82 - $1.35 $410 - $675
500 Added 3.07%
16,800 $15 Million
Q4 2023

Feb 05, 2024

BUY
$0.66 - $0.91 $462 - $637
700 Added 4.49%
16,300 $14.2 Million
Q3 2023

Oct 10, 2023

BUY
$0.85 - $1.43 $4,760 - $8,008
5,600 Added 56.0%
15,600 $14.4 Million
Q4 2022

Feb 13, 2023

BUY
$1.07 - $1.34 $10,700 - $13,400
10,000 New
10,000 $12.1 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Cora Capital Advisors LLC Portfolio

Follow Cora Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cora Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cora Capital Advisors LLC with notifications on news.